Correlation Between HCW Biologics and ABPRO P

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HCW Biologics and ABPRO P at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCW Biologics and ABPRO P into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HCW Biologics and ABPRO P, you can compare the effects of market volatilities on HCW Biologics and ABPRO P and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCW Biologics with a short position of ABPRO P. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCW Biologics and ABPRO P.

Diversification Opportunities for HCW Biologics and ABPRO P

-0.42
  Correlation Coefficient

Very good diversification

The 3 months correlation between HCW and ABPRO is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding HCW Biologics and ABPRO P in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ABPRO P and HCW Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCW Biologics are associated (or correlated) with ABPRO P. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ABPRO P has no effect on the direction of HCW Biologics i.e., HCW Biologics and ABPRO P go up and down completely randomly.

Pair Corralation between HCW Biologics and ABPRO P

Given the investment horizon of 90 days HCW Biologics is expected to generate 5.98 times more return on investment than ABPRO P. However, HCW Biologics is 5.98 times more volatile than ABPRO P. It trades about 0.13 of its potential returns per unit of risk. ABPRO P is currently generating about -0.5 per unit of risk. If you would invest  44.00  in HCW Biologics on August 30, 2024 and sell it today you would earn a total of  6.00  from holding HCW Biologics or generate 13.64% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.65%
ValuesDaily Returns

HCW Biologics  vs.  ABPRO P

 Performance 
       Timeline  
HCW Biologics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in HCW Biologics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, HCW Biologics sustained solid returns over the last few months and may actually be approaching a breakup point.
ABPRO P 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ABPRO P has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's fundamental drivers remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

HCW Biologics and ABPRO P Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HCW Biologics and ABPRO P

The main advantage of trading using opposite HCW Biologics and ABPRO P positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCW Biologics position performs unexpectedly, ABPRO P can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABPRO P will offset losses from the drop in ABPRO P's long position.
The idea behind HCW Biologics and ABPRO P pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity